Correlation Between Cyclo Therapeutics and Ubiquitech Software
Can any of the company-specific risk be diversified away by investing in both Cyclo Therapeutics and Ubiquitech Software at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclo Therapeutics and Ubiquitech Software into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclo Therapeutics and Ubiquitech Software, you can compare the effects of market volatilities on Cyclo Therapeutics and Ubiquitech Software and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclo Therapeutics with a short position of Ubiquitech Software. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclo Therapeutics and Ubiquitech Software.
Diversification Opportunities for Cyclo Therapeutics and Ubiquitech Software
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cyclo and Ubiquitech is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Cyclo Therapeutics and Ubiquitech Software in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ubiquitech Software and Cyclo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclo Therapeutics are associated (or correlated) with Ubiquitech Software. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ubiquitech Software has no effect on the direction of Cyclo Therapeutics i.e., Cyclo Therapeutics and Ubiquitech Software go up and down completely randomly.
Pair Corralation between Cyclo Therapeutics and Ubiquitech Software
Given the investment horizon of 90 days Cyclo Therapeutics is expected to under-perform the Ubiquitech Software. But the stock apears to be less risky and, when comparing its historical volatility, Cyclo Therapeutics is 51.1 times less risky than Ubiquitech Software. The stock trades about -0.03 of its potential returns per unit of risk. The Ubiquitech Software is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest 0.01 in Ubiquitech Software on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Ubiquitech Software or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cyclo Therapeutics vs. Ubiquitech Software
Performance |
| Timeline |
| Cyclo Therapeutics |
| Ubiquitech Software |
Cyclo Therapeutics and Ubiquitech Software Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cyclo Therapeutics and Ubiquitech Software
The main advantage of trading using opposite Cyclo Therapeutics and Ubiquitech Software positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclo Therapeutics position performs unexpectedly, Ubiquitech Software can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ubiquitech Software will offset losses from the drop in Ubiquitech Software's long position.| Cyclo Therapeutics vs. Eliem Therapeutics | Cyclo Therapeutics vs. Scpharmaceuticals | Cyclo Therapeutics vs. Milestone Pharmaceuticals | Cyclo Therapeutics vs. Seres Therapeutics |
| Ubiquitech Software vs. Now Corp | Ubiquitech Software vs. Holloman Energy Corp | Ubiquitech Software vs. Greater Cannabis | Ubiquitech Software vs. EVIO Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |